Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics.

Abstract

OBJECTIVE AND DESIGN:

A decrease of GH levels below 2 microg/l after an oral glucose tolerance test (OGTT) is still currently accepted as the gold standard for assessing cure in surgically treated acromegaly. Whether glucose-induced suppression of GH is accompanied by a restoration of normal GH late rebound has not yet been evaluated in this disease. In order to assess the restoration of normal GH regulation after removal of a pituitary adenoma, we have evaluated GH changes after an OGTT in a series of selected acromegalic patients (transsphenoidal surgery and lack of pituitary failure).

METHODS:

Twenty-nine patients (13 male, 16 female, age range 27-70 years) entered the study. Their neuroradiological imaging before neurosurgery showed microadenoma in 7, intrasellar macroadenoma in 8 and macroadenoma with extrasellar extension in 14. Plasma GH levels were assayed up to 300 min after glucose administration (75 g p.o.) and IGF-I on basal samples.

RESULTS:

Basal GH levels were below 5 microg/l in 20 patients and below 2 microg/l in 5 of these. Normal age-adjusted IGF-I levels were observed in 12 patients. GH values were suppressed below 2 microg/l during an OGTT in 13 patients, and below 1 microg/l in 7 of these. In 9 patients out of these 13, a marked rise in GH levels occurred after nadir. Baseline and nadir GH values of these 9 patients were not different from the corresponding values of the other 4 patients without OGTT-induced late GH peaks.

CONCLUSIONS:

GH rebound after GH nadir occurs in acromegalic patients considered as cured on the basis of OGTT-induced GH suppression and/or IGF-I normalization. The restoration of this physiological response could be regarded as a marker of recovered/preserved integrity of the hypothalamic-pituitary axis. Even though the reason for this GH rebound has not yet been elucidated (GHRH discharge?/end of somatostatin inhibition?), the lack of late GH peak in the patients regarded as cured by the usual criteria could be due to injury to the pituitary stalk caused by the adenoma or by surgical manipulation.

• Authors: R Attanasio, G Oppizzi, S Lodrini, D Dallabonzana, M Barausse, P Orlandi, N DaRe, R Cozzi
• Journal: European journal of endocrinology (Eur J Endocrinol) Vol. 140 Issue 1 Pg. 23-8 (Jan 1999) ISSN: 0804-4643 [Print] England
• PMID: 10037247 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Blood Glucose
• Insulin-Like Growth Factor I
• Growth Hormone

Topics

• Acromegaly (blood, physiopathology, surgery)
• Adult
• Aged
• Blood Glucose (analysis)
• Female
• Glucose Tolerance Test
• Growth Hormone (blood)
• Humans
• Insulin-Like Growth Factor I (analysis)
• Male
• Middle Aged
• Time Factors
• Treatment Outcome